STRENSIQ sol inj 80 mg/0.8ml (en 2ml flac) 12 pce
7680660860102
CH-66086
A16AB13
07.14.0.
1 / 3
google
Details
- Product number
- 6608602
- CPT
- -
- Packaging group
- 12
- Unit
- Durchstechflasche(n)
- Composition
- asfotasum alfa 100 mg, natrii chloridum, dinatrii phosphas heptahydricus, natrii dihydrogenophosphas monohydricus, aqua ad iniectabile q.s. ad solutionem pro 1 ml.
Articles (1)
Strensiq 100 mg/ml, Injektionslösung
Injektionslösung
12
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
100.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Authorization holder
Alexion Pharma GmbH
6340 Baar
Authorization information
- Swissmedic authorization number
- 66086
- Drug name
- Strensiq, Injektionslösung
- Galenic form
- LSPA
- ATC Code
- A16AB13
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 16/08/2016
- Authorization expiration date
- 31/12/9999
- IT number
- 07.14.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- STRENSIQ sol inj 80 mg/0.8ml (en 2ml flac) 12 pce
- Description (DE)
- STRENSIQ Inj Lös 80 mg/0.8ml (in 2ml Fl) 12 Stk
- Market launch
- 16/08/2016
- Narcotic (BTM)
- No